Table 3.
The recovery of the targeted phospholipids.
| Analytes | Recovery of added analytes (%, n=3) | |||||||
|---|---|---|---|---|---|---|---|---|
| Concentration added (nM) | Serum (set 1) | Supernatant (set 2) | ||||||
| Detected (nM) | Recovery (%) | RSD (%) | Detected (nM) | Recovery (%) | RSD(%) | |||
| SM(34:1) | 155.15 | 110.77±7.86 | 71.39 | 7.10 | 107.28±7.46 | 69.15 | 6.96 | |
| 51.24 | 33.61±4.06 | 65.59 | 12.07 | 32.30±3.15 | 63.03 | 9.76 | ||
| 7.69 | 4.83±0.18 | 62.8 | 3.82 | 5.07±0.30 | 65.93 | 5.92 | ||
| PC(34:2) | 330.00 | 284.17±11.12 | 86.11 | 3.91 | 280.07±15.66 | 84.87 | 5.59 | |
| 134.64 | 101.74±6.34 | 75.56 | 6.23 | 101.02±3.26 | 75.03 | 3.23 | ||
| 47.52 | 36.07±1.12 | 75.91 | 3.11 | 36.92±0.43 | 77.69 | 1.16 | ||
| PC(34:1) | 143.50 | 117.20±3.51 | 81.67 | 3.00 | 111.51±3.79 | 77.71 | 3.40 | |
| 95.84 | 73.11±3.56 | 76.28 | 4.59 | 72.87±0.93 | 76.03 | 1.27 | ||
| 47.39 | 34.26±0.37 | 72.29 | 1.09 | 36.94±2.37 | 77.93 | 6.42 | ||
| PC(36:4) | 139.46 | 138.23±7.45 | 99.11 | 5.39 | 141.66±4.27 | 101.57 | 3.01 | |
| 93.15 | 96.61±2.97 | 103.43 | 3.08 | 105.34±4.63 | 112.78 | 4.40 | ||
| 46.06 | 51.95±0.83 | 109.73 | 1.60 | 50.53±2.47 | 106.73 | 4.90 | ||
| PC(36:2) | 138.75 | 107.89±2.40 | 77.76 | 2.23 | 109.87±1.50 | 79.19 | 1.36 | |
| 92.67 | 77.24±1.40 | 83.12 | 1.81 | 68.97±1.68 | 74.22 | 2.43 | ||
| 45.83 | 35.97±1.68 | 78.50 | 4.67 | 36.71±1.84 | 80.10 | 5.02 | ||